Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC.
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Novel Treatment Combinations in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Restoring Sensitivity To Immunotherapy In Advanced Triple Negative Breast Cancer Exploiting Ceralasertib Priming Followed By Combined Durvalumab/Nab-Paclitaxel
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2